Physician profile
Robert S Baratz
NPI 1205828399
$3,052.89
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $223 · 2021: $1,180 · 2022: $805 · 2023: $346 · 2024: $85.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,313.87 | 2021-2024 | Vraylar, Ubrelvy |
| Vanda Pharmaceuticals INC. | $611.95 | 2021-2023 | Hetlioz |
| Novo Nordisk INC | $353.12 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $169.00 | 2019 | |
| Glaxosmithkline, LLC. | $157.44 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $114.59 | 2019-2023 | Eliquis |
| Allergan, INC. | $101.41 | 2019-2020 | |
| Amarin Pharma, INC. | $79.05 | 2021-2022 | |
| Bausch Health US, LLC | $44.53 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $39.93 | 2019 | |
| Exact Sciences Corporation | $20.40 | 2023 | Cologuard Collection Kit |
| Shire North American Group INC | $19.26 | 2019 | |
| Astellas Pharma US INC | $14.46 | 2019 | |
| Avion Pharmaceuticals | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baratz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.